Advertisement

Endocrine

, Volume 54, Issue 3, pp 578–587 | Cite as

Pulmonary hypertension in thyroid diseases

  • Pietro Scicchitano
  • Ilaria Dentamaro
  • Francesco Tunzi
  • Gabriella Ricci
  • Santa Carbonara
  • Fiorella Devito
  • Annapaola Zito
  • Anna Ciampolillo
  • Marco Matteo Ciccone
Review

Abstract

The influence of thyroid hormones on cardiovascular system is well established. Thyroid diseases can effectively enhance the alteration on cardiovascular system by influencing chronotropic and inotropic actions of the heart; altering the strength and the speed of contraction, the speed of relaxation, the duration of the potential of action, and the duration of the refractory period and atrio-ventricular conduction time; modulating circulation and peripheral vascular beds. One of the more intriguing insights in the connection between thyroid diseases and cardiovascular alterations is related to the evaluation of the influence of thyroid hormones on pulmonary vascular beds. Literature reported several studies regarding the association between both hypothyroidism and hyperthyroidism and the occurrence of increased vascular pulmonary arterial pressure. Nevertheless, the pathogenetic mechanisms able to explain such relationship are not fully understood. Many doubts still persist in the comprehension of the mechanisms of pulmonary hypertension in thyroid diseases. The aim of this review was to provide possible explanation about the possible interaction between pulmonary vascular beds and thyroid function in order to evaluate the possibility of novel perspectives in the general management of patients suffering from thyroid and cardiovascular diseases.

Keywords

Pulmonary hypertension Hyperthyroidism Hypothyroidism Endothelial function Thyroid hormones 

Notes

Compliance with ethical standards

Conflict of interest

None declared

References

  1. 1.
    H. Vargas-Uricoechea, A. Bonelo-Perdomo, C.H. Sierra-Torres, Effects of thyroid hormones on the heart. Clin. Investig. Arterioscler. 26, 296–309 (2014)CrossRefPubMedGoogle Scholar
  2. 2.
    H. Vargas-Uricoechea, C.H. Sierra-Torres, Thyroid hormones and the heart. Horm. Mol. Biol. Clin. Investig. 18, 15–26 (2014)PubMedGoogle Scholar
  3. 3.
    S. Mohr-Kahaly, G. Kahaly, J. Meyer, Cardiovascular effects of thyroid hormones. Z. Kardiol. 85, 219–231 (1996)PubMedGoogle Scholar
  4. 4.
    S. Vinzio, O. Morel, J.L. Schlienger, B. Goichot, Cellular mechanisms of thyroid hormone action. Presse. Med. 34, 1147–1152 (2005)CrossRefPubMedGoogle Scholar
  5. 5.
    B. Kim, S.D. Carvalho-Bianco, P.R. Larsen, Thyroid hormone and adrenergic signaling in the heart. Arq. Bras. Endocrinol. Metabol. 48, 171–175 (2004)CrossRefPubMedGoogle Scholar
  6. 6.
    M. Marvisi, L. Balzarini, C. Mancini, P. Mouzakiti, Thyroid gland and pulmonary hypertension. What’s the link? Panminerva Med. 55, 93–97 (2013)PubMedGoogle Scholar
  7. 7.
    M. Pappas, K. Mourouzis, H. Karageorgiou, C. Tesseromatis, I. Mourouzis, G. Kostopanagiotou, C. Pantos, D.V. Cokkinos, Thyroid hormone modulates the responsiveness of rat aorta to alpha1-adrenergic stimulation: an effect due to increased activation of beta2-adrenergic signaling. Int. Angiol. 28, 474–478 (2009)PubMedGoogle Scholar
  8. 8.
    C. Pantos, C. Mourouzis, M. Katramadou, T. Saranteas, I. Mourouzis, H. Karageorgiou, C. Tesseromatis, G. Kostopanagiotou, P. Asimacopoulos, D.V. Cokkinos, Decreased vascular reactivity to alpha1 adrenergic stimulation in the presence of hypothyroid state: a part of an adaptive response? Int. Angiol. 25, 216–220 (2006)PubMedGoogle Scholar
  9. 9.
    L. Sabatino, V. Lubrano, S. Balzan, C. Kusmic, S. Del Turco, G. Iervasi, Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones. Mol. Cell. Biochem. 399, 87–94 (2015)CrossRefPubMedGoogle Scholar
  10. 10.
    M.M. Ciccone, G. De Pergola, M.T. Porcelli, P. Scicchitano, P. Caldarola, M. Iacoviello, G. Pietro, F. Giorgino, S. Favale, Increased carotid IMT in overweight and obese women affected by Hashimoto’s thyroiditis: an adiposity and autoimmune linkage? BMC Cardiovasc. Disord. 10, 22 (2010)CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    M. Marvisi, C. Ajolfi, G. Civardi, R. Delsignore, Thyroid dysfunction and pulmonary hypertension. Recenti Prog. Med. 95, 443–446 (2004)PubMedGoogle Scholar
  12. 12.
    R. Senese, P. Lasala, C. Leanza, P. de Lange, New avenues for regulation of lipid metabolism by thyroid hormones and analogs. Front. Physiol. 5, 475 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    M.M. Ciccone, A. Zito, A. Ciampolillo, M. Gesualdo, P. Zaza, M. Rodio, M. Barbaro, S. Di Molfetta, P. Scicchitano, Pulmonary hypertension and Hashimoto’s thyroiditis: does a relationship exist? Endocrine 48, 621–628 (2015)CrossRefPubMedGoogle Scholar
  14. 14.
    L. Chaker, C. Baumgartner, M.A. Ikram, A. Dehghan, M. Medici, W.E. Visser, A. Hofman, N. Rodondi, R.P. Peeters, O.H. Franco, Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis. Eur. J. Epidemiol. 29, 791–800 (2014)CrossRefPubMedGoogle Scholar
  15. 15.
    N. Galiè, M. Humbert, J.L. Vachiery, S. Gibbs, I. Lang, A. Torbicki, G. Simonneau, A. Peacock, A. Vonk Noordegraaf, M. Beghetti, A. Ghofrani, M.A. Gomez Sanchez, G. Hansmann, W. Klepetko, P. Lancellotti, M. Matucci, T. McDonagh, L.A. Pierard, P.T. Trindade, M. Zompatori, M. Hoeper, V. Aboyans, A. Vaz Carneiro, S. Achenbach, S. Agewall, Y. Allanore, R. Asteggiano, L. Paolo Badano, J. Albert Barberà, H. Bouvaist, H. Bueno, R.A. Byrne, S. Carerj, G. Castro, Ç. Erol, V. Falk, C. Funck-Brentano, M. Gorenflo, J. Granton, B. Iung, D.G. Kiely, P. Kirchhof, B. Kjellstrom, U. Landmesser, J. Lekakis, C. Lionis, G.Y. Lip, S.E. Orfanos, M.H. Park, M.F. Piepoli, P. Ponikowski, M.P. Revel, D. Rigau, S. Rosenkranz, H. Völler, J. Luis Zamorano, ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37, 67–119 (2015)CrossRefPubMedGoogle Scholar
  16. 16.
    D.B. Badesch, K.M. Wynne, S. Bonvallet, N.F. Voelkel, C. Ridgway, B.M. Groves, Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann. Intern. Med. 119, 44–46 (1993)CrossRefPubMedGoogle Scholar
  17. 17.
    R.G. Chin, J. Fisher, Hypothyroidism and pulmonary hypertension: observation and speculation. Cardiovasc. Rev. Rep. 9, 789–796 (1986)Google Scholar
  18. 18.
    A.L. Curnock, R.A. Dweik, B.H. Higgins, H.F. Saadi, A.C. Arroliga, High prevalence of hypothyroidism in patients with primary pulmonary hypertension. Am. J. Med. Sci. 318, 289–292 (1999)CrossRefPubMedGoogle Scholar
  19. 19.
    J.W. Chu, P.N. Kao, J.L. Faul, R.L. Doyle, High Prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 122, 1668–1673 (2002)CrossRefPubMedGoogle Scholar
  20. 20.
    J.H. Li, R.E. Safford, J.F. Aduen, M.G. Heckman, J.E. Crook, C.D. Burger, Pulmonary hypertension and thyroid disease. Chest 132, 793–797 (2007)CrossRefPubMedGoogle Scholar
  21. 21.
    M. Satoh, K. Aso, T. Nakayama, K. Naoi, S. Ikehara, Y. Uchino, H. Shimada, S. Takatsuki, H. Matsuura, T. Saji, Autoimmune thyroid disease in children and adolescents with idiopathic pulmonary arterial hypertension. Circ. J. 74, 371–374 (2010)CrossRefPubMedGoogle Scholar
  22. 22.
    I. Klein, S. Danzi, Thyroid disease and the heart. Circulation 116, 1725–1735 (2007)CrossRefPubMedGoogle Scholar
  23. 23.
    Ichiki, T.: Thyroid hormone and vascular remodeling. J Atheroscler Thromb. Nov 11. [Epub ahead of print] (2015)Google Scholar
  24. 24.
    S. Wieshammer, F.S. Keck, H. Seibold, U. Loos, V. Hombach, E.F. Pfeiffer, Acute hypothyroidism has no effect on pulmonary vascular resistance. Klin. Wochenschr. 67, 530–534 (1989)CrossRefPubMedGoogle Scholar
  25. 25.
    C.C. Costa, M. Medeiros, K. Watanabe, P. Martin, T.L. Skare, Hashimoto thyroiditis may be associated with a subset of patients with systemic sclerosis with pulmonary hypertension. Rev. Bras. Reumatol. 54, 366–370 (2014)CrossRefPubMedGoogle Scholar
  26. 26.
    M.R. Nicolls, L. Taraseviciene-Stewart, P.R. Rai, D.B. Badesch, N.F. Voelkel, Autoimmunity and pulmonary hypertension: a perspective. Eur. Respir. J. 26, 1110–1118 (2005)CrossRefPubMedGoogle Scholar
  27. 27.
    J.M. Oldham, D. Kumar, C. Lee, S.B. Patel, S. Takahashi-Manns, C. Demchuk, M.E. Strek, I. Noth, Thyroid disease is prevalent and predicts survival in patients with idiopathic pulmonary fibrosis. Chest 148, 692–700 (2015)CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    L. Sweeney, N.F. Voelkel, Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension. Eur. J. Med. Res. 14, 433–442 (2009)CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    L. Siemińska, C. Wojciechowska, K. Walczak, A. Borowski, B. Marek, M. Nowak, D. Kajdaniuk, W. Foltyn, B. Kos-Kudła, Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6. Endokrynol Pol. 66, 394–403 (2015)CrossRefPubMedGoogle Scholar
  30. 30.
    A. Tvarijonaviciute, L. Jaillardon, J.J. Cerón, B. Siliart, Effects of thyroxin therapy on different analytes related to obesity and inflammation in dogs with hypothyroidism. Vet. J. 196, 71–75 (2013)CrossRefPubMedGoogle Scholar
  31. 31.
    F. Vargas, J.M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, J. Garcia-Estan, Vascular and renal function in experimental thyroid disorders. Eur. J. Endocrinol. 154, 197–212 (2006)CrossRefPubMedGoogle Scholar
  32. 32.
    L. Osmak-Tizon, M. Poussier, Y. Cottin, L. Rochette, Non-genomic actions of thyroid hormones: molecular aspects. Arch. Cardiovasc. Dis. 107, 207–211 (2014)CrossRefPubMedGoogle Scholar
  33. 33.
    P.J. Davis, F.B. Davis, Nongenomic actions of thyroid hormone. Thyroid 6, 497–504 (1996)CrossRefPubMedGoogle Scholar
  34. 34.
    R. Vicinanza, G. Coppotelli, C. Malacrino, T. Nardo, B. Buchetti, L. Lenti, F.S. Celi, S. Scarpa, Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells. Thyroid 23, 231–238 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    L.H. Duntas, E. Mantzou, D.A. Koutras, Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid 12, 1003–1007 (2002)CrossRefPubMedGoogle Scholar
  36. 36.
    T. Ittermann, S.E. Baumeister, H. Völzke, C. Wasner, U. Schminke, H. Wallaschofski, M. Nauck, J. Lüdemann, Are serum TSH levels associated with oxidized low-density lipoprotein? Results from the Study of Health in Pomerania. Clin. Endocrinol. (Oxf). 76, 526–532 (2012)CrossRefPubMedGoogle Scholar
  37. 37.
    T. Diekman, P.N. Demacker, J.J. Kastelein, A.F. Stalenhoef, W.M. Wiersinga, Increased oxidizability of low-density lipoproteins in hypothyroidism. J. Clin. Endocrinol. Metab. 83, 1752–1755 (1998)CrossRefPubMedGoogle Scholar
  38. 38.
    A.S. Tamajusuku, M.A. Carrillo-Sepúlveda, E. Braganhol, M.R. Wink, J.J. Sarkis, M.L. Barreto-Chaves, A.M. Battastini, Activity and expression of ecto-5′-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells. Mol. Cell. Biochem. 289, 65–72 (2006)CrossRefPubMedGoogle Scholar
  39. 39.
    S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Chiadoni, A. Salvetti, E. Ferrannini, F. Monzani, Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J. Clin. Endocrinol. Metab. 88, 3731–3737 (2003)CrossRefPubMedGoogle Scholar
  40. 40.
    K. Fukuyama, T. Ichiki, I. Imayama, H. Ohtsubo, H. Ono, Y. Hashiguchi, A. Takeshita, K. Sunagawa, Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity. Arterioscler. Thromb. Vasc. Biol. 26, 2049–2055 (2006)CrossRefPubMedGoogle Scholar
  41. 41.
    M. Hostiuc, G.C. Curca, D. Dermengiu, C. Sinescu, S. Hostiuc, Can subclinical hypothyroidism explain some sudden deaths due to pulmonary embolism without evident risk factors? Med. Hypotheses 76, 855–857 (2011)CrossRefPubMedGoogle Scholar
  42. 42.
    C. Erem, O. Ucuncu, M. Yilmaz, M. Kocak, I. Nuhoglu, H.O. Ersoz, Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine 35, 75–80 (2009)CrossRefPubMedGoogle Scholar
  43. 43.
    O. Araz, E. Yilmazel Ucar, A. Yalcin, D. Pulur, H. Acemoglu, H. Tas, L. Saglam, M. Akgun, A. Mirici, The incidence and severity of pulmonary hypertension in obstructive sleep apnea with hypothyroidism. Med. Sci. Monit. 19, 883–887 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    M. Marvisi, M. Brianti, G. Marani, R. Del Borello, M.L. Bortesi, A. Guariglia, Hyperthyroidism and pulmonary hypertension. Respir. Med. 96, 215–220 (2002)CrossRefPubMedGoogle Scholar
  45. 45.
    M. Marvisi, P. Zambrelli, M. Brianti, G. Civardi, R. Lampugnani, R. Delsignore, Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. Eur. J. Intern. Med. 17, 267–271 (2006)CrossRefPubMedGoogle Scholar
  46. 46.
    R. Alcázar, M. Rey, P. de Sequera, R. Alegre, A. Rovira, C. Caramelo, The reversibility of pulmonary hypertension associated with autoimmune hyperthyroidism. Rev. Esp. Cardiol. 48, 142–144 (1995)PubMedGoogle Scholar
  47. 47.
    C.W. Siu, X.H. Zhang, C. Yung, A.W. Kung, C.P. Lau, H.F. Tse, Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J. Clin. Endocrinol. Metab. 92, 1736–1742 (2007)CrossRefPubMedGoogle Scholar
  48. 48.
    J. Mercé, S. Ferrás, C. Oltra, E. Sanz, J. Vendrell, I. Simón, M. Camprubí, A. Bardají, C. Ridao, Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. Am. J. Med. 118, 126–131 (2005)CrossRefPubMedGoogle Scholar
  49. 49.
    C.M. Trapp, R.W. Elder, A.T. Gerken, A.B. Sopher, S. Lerner, G.S. Aranoff, E.B. Rosenzweig, Pediatric pulmonary arterial hypertension and hyperthyroidism: a potentially fatal combination. J. Clin. Endocrinol. Metab. 97, 2217–2222 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    R. Obeid, V.K. Kalra, P. Arora, F. Quist, K.C. Moltz, N.S. Chouthai, Neonatal thyrotoxicosis presenting as persistent pulmonary hypertension. BMJ Case Rep. (2012). doi:  10.1136/bcr.02.2012.5939
  51. 51.
    D. O’Donovan, C. McMahon, C. Costigan, P. Oslizlok, D. Duff, Reversible pulmonary hypertension in neonatal Graves disease. Ir. Med. J. 90, 147–148 (1997)PubMedGoogle Scholar
  52. 52.
    B. Agraou, O. Tricot, A. Strecker, R. Bresson, F. Leroy, P. Langlois, B. Lauwerier, J.J. Dujardin, Hyperthyroidism associated with pulmonary hypertension. Arch. Mal. Coeur Vaiss. 89, 765–768 (1996)PubMedGoogle Scholar
  53. 53.
    G.A. Brent, Clinical practice. Graves’ disease. N Engl J Med. 358, 2594–2605 (2008)CrossRefPubMedGoogle Scholar
  54. 54.
    H. Ikram, The nature and prognosis of thyrotoxic heart disease. Q. J. Med. 54, 19–28 (1985)PubMedGoogle Scholar
  55. 55.
    M.O. Hegazi, S. Ahmed, Atypical clinical manifestations of Graves’ disease: an analysis in depth. J. Thyroid Res. 2012, 768019 (2012)CrossRefPubMedGoogle Scholar
  56. 56.
    M.O. Hegazi, A. El Sayed, H. El Ghoussein, Pulmonary hypertension responding to hyperthyroidism treatment. Respirology 13, 923–925 (2008)CrossRefPubMedGoogle Scholar
  57. 57.
    Y. Paran, A. Nimrod, Y. Goldin, D. Justo, Pulmonary hypertension and predominant right heart failure in thyrotoxicosis. Resuscitation 69, 339–341 (2006)CrossRefPubMedGoogle Scholar
  58. 58.
    R. Di Giovambattista, Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure. Cardiovasc. Ultrasound. 6, 29 (2008)CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    B. Biondi, Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur. J. Endocrinol. 167, 609–618 (2012)CrossRefPubMedGoogle Scholar
  60. 60.
    V.H. Tam, L.M. Fung, Severe right heart failure in two patients with thyrotoxicosis. Hong Kong Med. J. 14, 321–323 (2008)PubMedGoogle Scholar
  61. 61.
    A. Yazar, O. Döven, S. Atis, R. Gen, C. Pata, E.E. Yazar, A. Kanik, Systolic pulmonary artery pressure and serum uric acid levels in patients with hyperthyroidism. Arch. Med. Res. 34, 35–40 (2003)CrossRefPubMedGoogle Scholar
  62. 62.
    A. Soroush-Yari, S. Burstein, G.W. Hoo, S.M. Santiago, Pulmonary hypertension in men with thyrotoxicosis. Respiration 72, 90–94 (2005)CrossRefPubMedGoogle Scholar
  63. 63.
    T. Sugiura, S. Yamanaka, H. Takeuchi, N. Morimoto, M. Kamioka, Y. Matsumura, Autoimmunity and pulmonary hypertension in patients with Graves’ disease. Heart Vessel. 30, 642–646 (2015)CrossRefGoogle Scholar
  64. 64.
    V.O. Kheyfets, L. Rios, T. Smith, T. Schroeder, J. Mueller, S. Murali, D. Lasorda, A. Zikos, J. Spotti, J.J. Reilly Jr, E.A. Finol, Patient-specific computational modeling of blood flow in the pulmonary arterial circulation. Comput. Methods Programs Biomed. 120, 88–101 (2015)CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    B.J. Xu, J. Chen, X. Chen, X.W. Liu, S. Fang, Q. Shu, L. Hu, S.S. Shi, L.Z. Du, L.H. Tan, High shear stress-induced pulmonary hypertension alleviated by endothelial progenitor cells independent of autophagy. World J. Pediatr. 11, 171–176 (2015)CrossRefPubMedGoogle Scholar
  66. 66.
    A. Postles, A.R. Clark, M.H. Tawhai, Dynamic blood flow and wall shear stress in pulmonary hypertensive disease. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2014, 5671–5674 (2014)PubMedGoogle Scholar
  67. 67.
    S. Song, A. Yamamura, H. Yamamura, R.J. Ayon, K.A. Smith, H. Tang, A. Makino, J.X. Yuan, Flow shear stress enhances intracellular Ca2 + signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension. Am. J. Physiol. Cell Physiol. 307, C373–383 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    N. Dereddy, J. Huang, M. Erb, S. Guzel, J.H. Wolk, S.S. Sett, M.H. Gewitz, R. Mathew, Associated inflammation or increased flow-mediated shear stress, but not pressure alone, disrupts endothelial caveolin-1 in infants with pulmonary hypertension. Pulm. Circ. 2, 492–500 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    T. Kasahara, K. Tsunekawa, K. Seki, M. Mori, M. Murakami, Regulation of iodothyronine deiodinase and roles of thyroid hormones in human coronary artery smooth muscle cells. Atherosclerosis 186, 207–214 (2006)CrossRefPubMedGoogle Scholar
  70. 70.
    A. Al Husseini, G. Bagnato, L. Farkas, J. Gomez-Arroyo, D. Farkas, S. Mizuno, D. Kraskauskas, A. Abbate, B. Van Tassel, N.F. Voelkel, H.J. Bogaard, Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats. Eur. Respir. J. 41, 104–114 (2013)CrossRefPubMedGoogle Scholar
  71. 71.
    Y.J. Lai, G.J. Chang, Y.H. Yeh, J.H. Pang, C.C. Huang, W.J. Chen, Propylthiouracil attenuates experimental pulmonary hypertension via suppression of pen-2, a key component of gamma-secretase. PLoS ONE 10, e0137426 (2015)CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    F.B. Davis, S.A. Mousa, L. O’Connor, S. Mohamed, H.Y. Lin, H.J. Cao, P.J. Davis, Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ. Res. 94, 1500–1506 (2004)CrossRefPubMedGoogle Scholar
  73. 73.
    R. Thurnheer, R. Jenni, E.W. Russi, P. Greminger, R. Speich, Hyperthyroidism and pulmonary hypertension. J. Intern. Med. 242, 185–188 (1997)CrossRefPubMedGoogle Scholar
  74. 74.
    S. Vallabhajosula, S. Radhi, C. Cevik, R. Alalawi, R. Raj, K. Nugent, Hyperthyroidism and pulmonary hypertension: an important association. Am. J. Med. Sci. 342, 507–512 (2011)CrossRefPubMedGoogle Scholar
  75. 75.
    J.H. Suk, K.I. Cho, S.H. Lee, H.G. Lee, S.M. Kim, T.I. Kim, M.K. Kim, Y.K. Shong, Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves’ disease: before and after antithyroid treatment. J. Endocrinol. Invest. 34, e229–234 (2011)PubMedGoogle Scholar
  76. 76.
    S. Ocak, F. Feoli, J. Fastrez, D. Butenda, C. Litvine, I.M. Colin, J.P. d’Odémont, Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis. Eur. Respir. Rev. 18, 125–128 (2009)PubMedGoogle Scholar
  77. 77.
    P. Caturegli, A. De Remigis, N.R. Rose, Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun. Rev. 13, 391–397 (2014)CrossRefPubMedGoogle Scholar
  78. 78.
    S. Rached, R.A. Athanazio, S.A. Dias Jr, C. Jardim, R. Souza, Systemic corticosteroids as first-line treatment in pulmonary hypertension associated with POEMS syndrome. J. Bras. Pneumol. 35, 804–808 (2009)CrossRefPubMedGoogle Scholar
  79. 79.
    M. Armigliato, R. Paolini, S. Aggio, S. Zamboni, M.P. Galasso, P. Zonzin, G. Cella, Hyperthyroidism as a cause of pulmonary arterial hypertension: a prospective study. Angiology 57, 600–606 (2006)CrossRefPubMedGoogle Scholar
  80. 80.
    N. Patel, W.J. Inder, C. Sullivan, G. Kaye, An audit of amiodarone-induced thyrotoxicosis—do anti-thyroid drugs alone provide adequate treatment? Heart Lung Circ. 23, 549–554 (2014)CrossRefPubMedGoogle Scholar
  81. 81.
    E. Roti, R. Minelli, E. Gardini, L. Bianconi, L.E. Braverman, Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. Arch. Intern. Med. 153, 886–892 (1993)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Pietro Scicchitano
    • 1
  • Ilaria Dentamaro
    • 2
  • Francesco Tunzi
    • 3
  • Gabriella Ricci
    • 2
  • Santa Carbonara
    • 2
  • Fiorella Devito
    • 2
  • Annapaola Zito
    • 2
  • Anna Ciampolillo
    • 4
  • Marco Matteo Ciccone
    • 2
  1. 1.Cardiology SectionHospital of Ostuni, ASL BROstuniItaly
  2. 2.Section of Cardiovascular Diseases, Department of Emergency and Organ TransplantationUniversity of BariBariItaly
  3. 3.Cardiology SectionHospital of Gallipoli, ASL LELecceItaly
  4. 4.Section of Endocrinology, Department of Emergency and Organ TransplantationUniversity of BariBariItaly

Personalised recommendations